Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08YWK
|
|||
Former ID |
DIB006485
|
|||
Drug Name |
FX-006
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Phase 3 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H31FO6
|
|||
Canonical SMILES |
CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C
|
|||
InChI |
1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1
|
|||
InChIKey |
YNDXUCZADRHECN-JNQJZLCISA-N
|
|||
CAS Number |
CAS 76-25-5
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:71418
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02357459) Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.